Skip to content
Bruker Dynamic Biosensors logo — Bruker Dynamic Biosensors provides analytical systems for th...

Bruker Dynamic Biosensors

Bruker Dynamic Biosensors provides analytical systems for the characterization of biomolecules & molecular interactions.

Founded 2013 Germany Munchen, Germany 54 employees Series A Biopharma, Biotechnology +2

General Information

Company Name Bruker Dynamic Biosensors
Founded Year 2013
Location Germany Munchen, Germany
Employees 54
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Series A
Business Model B2B, E Commerce
Revenue Model Product Sales, One Time Purchase, Licensing
Offices as of Sep 2026
‏München‏، ‏Bayern‏ ‏81379‏، ‏DE‏, ‏München‏، ‏Bayern‏ ‏81379‏، ‏DE‏ ‏Woburn‏، ‏Massachusetts‏ ‏01801‏، ‏US‏, ‏Woburn‏، ‏Massachusetts‏ ‏01801‏، ‏US‏
Social

BounceWatch is an independent company data service, not affiliated with Bruker Dynamic Biosensors. To contact Bruker Dynamic Biosensors, visit dynamic-biosensors.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Bruker Dynamic Biosensors compare?

A PDF of Bruker Dynamic Biosensors and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Bruker Dynamic Biosensors soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Bruker Dynamic Biosensors

Bruker Biosensors is a cutting-edge player in the analytical systems sector, specializing in the characterization of biomolecules and molecular interactions. Established in 2013 and headquartered in Germany, the company targets the Biopharma, Biotechnology, Health Care, and Pharmaceutical industries. Their innovative solutions enable significant advancements in drug discovery, life sciences research, and cell and gene therapies.

With a focus on providing state-of-the-art instruments and consumables for the detailed analysis of biomolecular interactions on biochips and single cells, Bruker Biosensors positions itself as a pivotal contributor to future healthcare advancements.

The last financial milestone for the company was a Series A investment on 01 March 2016, led by UVC Partners. As the company continues its trajectory of innovation, it presents a compelling opportunity for investors interested in transformative healthcare technologies.

Business keywords: Analytical Systems, Biomolecular Characterization, Molecular Interactions, Biochips, Single Cell Analysis, Drug Discovery, Life Science Research, Cell & Gene Therapies, Biophysical Analysis, Electrically Switchable Nanolevers, Fluorescence Proximity Sensing, Molecular Dynamics, Binding Kinetics, Conformational Change, Bispecific Binders

Services & Products

switchSENSE Technology
heliX Biosensor Instruments
scIC Technology
proFIRE Instrumentation for Conjugation
heliOS Software for Data Analysis

Target Customers

Pharmaceutical Researchers Biotech Companies Academic Research Institutions Synthetic Biologists Environmental Researchers

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed 1
UVC Partners
01 Mar 2016
Series A Undisclosed 1
UVC Partners
13 May 2015
Seed Round Undisclosed 4
UVC Partners, Bayern Kapital +2
19 Dec 2012

Bruker Dynamic Biosensors Alternatives & Competitors

View All Alternatives
Bruker Dynamic Biosensors vs

Smarter solutions for Life Science

24 employees
Biotechnology, Health Care
Bruker Dynamic Biosensors vs

Mapping the universe of biology 🧬

IPO
219 employees
Biotechnology, Health Care
Bruker Dynamic Biosensors vs
Reaction Biology
Reaction Biology United States

Contract research organization with commitment to quality data and quality support. Let's Discover T...

Acquired
146 employees
Biotechnology, Pharmaceutical

FAQ About Bruker Dynamic Biosensors

Bruker Dynamic Biosensors provides analytical systems for the characterization of biomolecules & molecular interactions.
Bruker Dynamic Biosensors was founded in 2013.
Bruker Dynamic Biosensors is headquartered in Munchen, Germany. As of Sep 2026, it also has offices in ‏München‏، ‏Bayern‏ ‏81379‏، ‏DE‏, ‏München‏، ‏Bayern‏ ‏81379‏، ‏DE‏ and ‏Woburn‏، ‏Massachusetts‏ ‏01801‏، ‏US‏, ‏Woburn‏، ‏Massachusetts‏ ‏01801‏، ‏US‏.
Bruker Dynamic Biosensors operates in Biopharma, Biotechnology, Health Care and Pharmaceutical. Its work centres on Analytical Systems, Biomolecular Characterization, Molecular Interactions and Biochips. Its customers include Pharmaceutical Researchers, Biotech Companies and Academic Research Institutions.
Bruker Dynamic Biosensors has a B2B and E Commerce business model. Its revenue comes from Product Sales, One Time Purchase and Licensing.
Bruker Dynamic Biosensors has approximately 54 employees.
Bruker Dynamic Biosensors has completed 3 funding rounds. The latest funding stage is Series A.
Bruker Dynamic Biosensors offers: switchSENSE Technology, heliX Biosensor Instruments, scIC Technology, proFIRE Instrumentation for Conjugation, heliOS Software for Data Analysis.
Top alternatives and competitors to Bruker Dynamic Biosensors include ATCG India, NanoString Technologies, Inc., Reaction Biology, Quantum-Si, Trince. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bruker Dynamic Biosensors and ATCG India are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bruker Dynamic Biosensors, https://bouncewatch.com/company/dynamic-biosensors, updated 26 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout